Suzanne Robertson
CEO and Founder of Matrix Biologics
Dr. Suzie Robertson, Pharm.D. is a clinical pharmacist, healthcare strategist, and business developer with nearly two decades of leadership experience across the healthcare continuum. She is recognized for bridging clinical excellence with innovation, helping organizations improve patient safety, operational performance, and care delivery models.
As a Clinical Informaticist, Dr. Robertson plays a key role at Phoenix Children’s Hospital, leading systems and solutions initiatives that support business growth while advancing medication safety and quality outcomes. Her work centers on designing safer, smarter healthcare systems that protect and improve the lives of patients.
She earned her Bachelor’s degree in Biochemistry and Cellular Biology from the University of California, San Diego (UCSD) and her Doctor of Pharmacy from the University of California, San Francisco (UCSF). She completed a pediatric-focused residency at Rady Children’s Hospital with specialization in medication safety, reinforcing her commitment to protecting vulnerable populations.
Dr. Robertson’s experience spans hospital, outpatient, retail, and integrative care settings, giving her a uniquely broad perspective on healthcare delivery. She is particularly passionate about leveraging data analytics, emerging technologies, and personalized therapeutic approaches to drive measurable improvements in outcomes.
She is also the founder of Matrix Biologics, an innovation-driven company dedicated to advancing patient care and quality of life through forward-thinking, outcome-focused healthcare solutions. Through her clinical leadership and entrepreneurial vision, Dr. Robertson continues to shape the future of safe, effective, and patient-centered care.
Erin Keyes
Chief Technology and Provider Excellence Officer
Erin Keyes currently holds the distinguished role of Chief Technology & Provider Excellence Officer, bringing a rare combination of scientific depth, healthcare technology strategy, and operational leadership to Matrix Biologics.
Keyes is a healthcare technology strategist and operational expert with a foundation in molecular biology. She began her career in benchtop human physiology research at the University of Michigan, then earned both her Master of Public Health (MPH) and MBA from Emory University, with a focus on translational research and epidemiological frameworks for responsibly bringing new interventions to market.
She worked with the CDC, FDA, CIA, Department of Defense, and other federal agencies as a fellow, senior researcher, and consultant through Deloitte, where she was first exposed to bioregulators and peptides in a bioterrorism and national preparedness context, shaping her lifelong commitment to safety, rigor, and responsible innovation.
Keyes later transitioned into startups, founding, scaling, and acquiring healthcare delivery and technology-enabled clinical organizations centered on operational excellence and next-generation care models. She has guided multiple organizations through funding and acquisition, with particular expertise in integrating digital platforms, AI-enabled tools, and emerging clinical technologies into scalable, compliant healthcare operations.
Most recently, Erin founded a consulting firm partnering with providers, clinics, suppliers, training institutes, and technology companies to advance regenerative care and cellular medicine. Over the past five years, her work has focused extensively on peptides, biologics, and emerging molecules, including the development of elite clinical protocols, provider education, gray-zone compliance navigation, and operational optimization across brick-and-mortar clinics, telehealth platforms, compound pharmacies, and research organizations.
Keyes’ work uniquely blends scientific rigor with entrepreneurial execution, applying systems-level thinking to drive scalable, outcomes-focused innovation across clinical, cellular, and virtual care ecosystems, making her a trusted leader at the intersection of science, technology, providers, and patients.
Dr. Lauren Beardsley, NMD
Chief Medical Officer
Dr. Lauren Beardsley, NMD is a Scottsdale-based Naturopathic Medical Doctor specializing in self-health, patient empowerment, and lifestyle medicine. With a strong clinical foundation in endocrinology, particularly autoimmune and complex chronic conditions, Dr. Beardsley is known for her ability to translate advanced medical science into practical, patient-centered solutions. Her approach extends far beyond symptom management or diagnosis; she is deeply committed to helping individuals actively build health, resilience, and longevity from the inside out.
Driven by both clinical expertise and personal experience, Dr. Beardsley’s philosophy is rooted in understanding the “why” behind disease and using that insight as a catalyst for meaningful, sustainable transformation. Her own journey through significant health challenges shaped her belief that optimal wellness is achieved through education, accountability, and strategic intervention, empowering patients to become active participants in their healing process.
For nearly a decade, Dr. Beardsley has been at the forefront of Regenerative Medicine, integrating cutting-edge cellular and biologic advancements into her clinical practice. She brings extensive experience in Exosome Therapy, utilizing this next-generation modality to support cellular communication, modulate inflammation, and enhance the body’s innate repair and recovery mechanisms. Her work reflects a deep respect for both the science behind regenerative therapies and the responsibility required to implement them safely and effectively.
Dr. Beardsley’s regenerative practice bridges rigorous scientific standards with compassionate, whole-person care. She is passionate about advancing education for both patients and providers, championing evidence-based innovation, and helping elevate the standard of care within regenerative medicine. Through her leadership, she continues to shape a future where precision, safety, and empowerment define how advanced therapies are delivered, and how lives are transformed.
Partnerships with Clinics
Our Mission
At Matrix Biologics, our mission is to transform 1 million lives by advancing curative outcomes through innovative regenerative therapies.
The Matrix Core 6 - Our Values
Above & Beyond Partnership (The Gold Standard)
We don’t just supply products, we show up as strategic partners. We go above and beyond to support providers with exceptional service, operational insight, and high-quality biologics, helping them elevate their practice and deliver consistently excellent outcomes.
Provider-First Empowerment
Providers are at the center of everything we build. From education and protocols to technology and support, we empower clinicians to practice with confidence, autonomy, and clarity, without compromise on safety or outcomes.
Integrity, Transparency & Trust
We operate with uncompromising integrity. Every product, recommendation, and partnership is grounded in transparency, regulatory responsibility, and evidence-based standards, earning long-term trust with providers and their patients.
Collaborative Growth & Support
We believe the best outcomes are built together. Through collaboration, shared knowledge, and ongoing support, we work alongside providers to strengthen their clinical success, business growth, and professional community.
Clinical Quality & Safety Excellence
Quality and safety are non-negotiable. We hold ourselves to the highest standards in sourcing, validation, and education, so providers can confidently deliver regenerative therapies that meet the demands of modern medicine.
Education-Driven Innovation
We are committed to lifelong learning and responsible innovation. By investing in education, research, and emerging technologies, we help providers stay ahead of the curve in regenerative medicine while maintaining clinical integrity.